Ivan Anya
Within the domain of cannabis's intricate interactions with the human mind, the rise of cannabis-induced psychosis has ignited a fervent quest to decipher the genetic foundations of this phenomenon. As scientists probe the nuanced interplay between genes and psychosis, a consistent theme has come to fore: the dopaminergic pathways. Amidst this terrain, two genes, COMT and AKT1, have emerged as the focal points of extensive genetic investigations. This voyage into the genetic connections with cannabis-induced psychosis initiates a fresh chapter in mental health exploration, illuminating the molecular complexities that impact vulnerability and potentially charting a course for precise interventions.
Compartilhe este artigo
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Hindi 